While the positive news about Moderna’s coronavirus vaccine trials is understandably exciting, the story behind their success offers organizations in every sector a dramatic opportunity to take a giant leap forward in their own industries. Among the key players quietly helping Moderna drive efficiencies at a previously unthinkable scale is Harvard Business School professor and…
How and why are some industry newcomers able to displace well-established giants in record time? According to Karim Lakhani, Harvard Business School professor and expert on AI-driven operating models, the answer lies in digital transformation. His latest case study, which documented the development of Moderna’s COVID-19 vaccine, offers dramatic proof that an AI-centered model offers organizations a powerful…
